71 – 80 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
-
Mark
Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study).
(
- Contribution to journal › Article
- 2002
-
Mark
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17 beta-estradiol and norethisterone acetate
(
- Contribution to journal › Article
- 2001
-
Mark
Ovarian tumors. Prevalence, malignancy risk and significance of the Plasminogen activation system.
2001)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
(
- Contribution to journal › Article
- 1998
-
Mark
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
(
- Contribution to journal › Article